Dry-process granulating machine for anti-tumor medicines

Abstract

The invention relates to a dry-process granulating machine for anti-tumor medicines. The dry-process granulating machine comprises a box body, and a material conveying device, an upper press roll, a lower press roll, a crushing mechanism and a granulating mechanism which are arranged on the box body, wherein a front cover mechanism is arranged at the outer side of the box body; the upper press roll, the lower press roll, the crushing mechanism and the granulating mechanism are respectively arranged in the front cover mechanism, and form a granulating area together with the front cover mechanism; a material charge device is arranged on the material conveying device, and the front cover mechanism is connected with a material discharge device; the front cover mechanism comprises a front coverframework, a front cover back panel and a front cover front panel, the front cover back panel is arranged at one side of the front cover framework, and the front cover front panel is arranged at theother side of the front cover framework; an installation hole of the upper press roll, an installation hole of the lower press roll, an installation hole of the crushing mechanism and an installationhole of the granulating mechanism are formed in the front cover back panel; one side of the front cover framework is provided with a material inlet, and is connected with the material conveying deviceby the material inlet via a flange. The dry-process granulating machine has the beneficial effects that the structure of the front cover mechanism is compact, the design is reasonable, and the good sealing property of the front cover structure is improved.

Description

technical field [0001] The invention relates to the technical field of pharmaceutical equipment, in particular to a dry granulator for antitumor drugs. Background technique [0002] During the granulation production of powder materials, when the existing powder materials are produced, the hinged front cover door is generally used to close the granulation area, which results in direct contact between the product and the air. The existing granulation equipment can meet the granulation production of general materials. For some special materials, such as toxic materials, they cannot be in direct contact with the air, and the production packaging cannot be exposed to the air. Therefore, the structure of the prior art granulation equipment is not suitable. Imperfect, there are certain deficiencies. Contents of the invention [0003] Aiming at the problems existing in the prior art, the object of the present invention is to provide a dry granulator for antineoplastic drugs with ...

AI Technical Summary

Problems solved by technology

[0002] During the granulation production of powder materials, when the existing powder materials are produced, the hinged front cover door is generally used to close the granulation area, which results in direct contact between the product and the air

The existing granulation equipment can meet the granulation production of general materials. For some special materials, such as toxic materials, they cannot be in direct contact with the air, and the production packaging cannot be exposed to the air. Therefore, the structure of the prior art granulation equipment is not Imperfect, there are certain deficiencies

Images